1 to 2 mL per 100 pounds of body weight
Individuals with kidney disease, certain cancers, or high blood pressure should consult their physician before use
The gradual dosing schedule helps minimize side effects and improves tolerability
Patients on tirzepatide were twice as likely to lose at least 25% of their body weight, and nearly one in five (19.7%) lost 30% or more, compared to fewer than one in fourteen (6.9%) on semaglutide.[1] Both medications also improved blood pressure, blood sugar, and cholesterol levels, with greater improvements seen in the tirzepatide group, which tracked with the larger weight reduction.[1] The safety profiles were similar
Interestingly, a study in 2003 showed that those who underwent coronary angiography and died of heart attacks had much lower glutathione peroxidase than those who survived (8)
JoinSkinny's medication options include GLP-1 and GLP-1 + GIP treatment, with the specific compound, formulation, and route determined by the prescribing provider rather than selected by the patient at checkout